666

HANDA PHARMACEUTICALS INC

No trades
See on Supercharts

6620 fundamentals

HANDA PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 6620 for the last quarter is 300.03 M TWD, and it's 25.00% higher compared to the previous quarter. The net income of Q4 23 is 86.83 M TWD.

Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income